37 Canadian oncologists got together in a consensus panel to talk about biomarkers and histologic subtypes of non-small cell lung cancer.
NSCLC: Use of biomarkers in prognosis, treatment
NSCLC: Use of biomarkers in prognosis…
NSCLC: Use of biomarkers in prognosis, treatment
37 Canadian oncologists got together in a consensus panel to talk about biomarkers and histologic subtypes of non-small cell lung cancer.